124
Views
29
CrossRef citations to date
0
Altmetric
Original Articles

Serum IgA-Promoting Effects Induced by Feed Loads Containing Isolated Deoxynivalenol (DON) in Growing Piglets

, , , , , , , , & show all
Pages 1051-1067 | Received 01 Sep 2003, Accepted 01 Jan 2003, Published online: 12 Aug 2010
 

Abstract

Deoxynivalenol (DON), a Fusarium toxin belonging to the trichothecene group, has been reported to produce a variety of adverse health effects in farm animals, such as inhibition of protein synthesis, reduction of feed intake, and alteration of the immune system. In pigs, the effects of increasing levels of chemically pure DON in a semisynthetic diet on performance, health, and serum immunglobulin A (IgA) levels were examined. A diet, without grain components and trichothecene free (8 main trichothecenes), with doses of 0, 300, 600, and 1200 μg pure DON/kg was fed to 34 female pigs for a period of 8 wk after weaning under standardized conditions. Body weight gain and biochemical and hematological values in the blood and serum, including concentrations of IgA, blood glucose, cortisol, and insulinlike growth factor 1 (IGF-1), were determined. Increasing levels of DON in the feed induced a significant depression of glucose levels. Cortisol and IGF-1 levels were not significantly affected but differed between groups at the end of the experiment. A significant increase of IgA concentration in the serum even at a dosage level of 600 μg DON/kg feed was observed. This is the first report demonstrating in vivo that limited dosages of DON are able to stimulate IgA levels in the serum of growing piglets.

This work was supported by the Deutsche Forschungsgemeinschaft (German Research Council), Bonn, by a grant to the research group “Fusarium toxins: Survey, prophylaxis and effects on animals” (Dr 92/8). The authors thank H. Steingaß for compilation of diet composition and the staff of the experimental station, especially V. Fanelli, for excellent animal care. The skilled technical assistance of the laboratory staff is gratefully acknowledged.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.